INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1997

Oral MSG challenge in sensitive individuals increased symptom severity and specific symptoms like headache and numbness compared to placebo.

In 61 self-identified MSG-sensitive subjects, oral challenges were conducted with MSG or placebo, followed by rechallenge with varying doses (placebo, 1.25, 2.5, and 5 gm MSG) in those reacting to a single agent. On initial challenge, 29.5% responded to neither, 9.8% to both, 24.6% to placebo, and 36.1% to MSG (p = 0.324). Total and average symptom severity scores were higher after MSG (374 and 80) than placebo (232 and 56; p = 0.026 and 0.018). Headache, muscle tightness, numbness/tingling, general weakness, and flushing were significantly more frequent after MSG, with an apparent threshold dose of 2.5 gm MSG.

Study type
Double-blind randomized crossover oral challenge study
Who was studied
61 self-identified MSG-sensitive subjects
What was measured
Reproduction of specific symptoms (>2 symptoms) and symptom severity

THE PAPER

The monosodium glutamate symptom complex: assessment in a double-blind, placebo-controlled, randomized study.

Yang WH, Drouin MA, Herbert M, Mao Y, Karsh J. J Allergy Clin Immunol, 1997.

PubMed 9215242 ↗DOI 10.1016/s0091-6749(97)80008-5 ↗

Food safety & contaminantsOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.